We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

By HospiMedica International staff writers
Posted on 28 Sep 2026

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. More...

General large language models can also struggle to retrieve evidence matched to an individual patient’s history. With an estimated 86% of medical decisions lacking high-quality evidence, hospitals need tools that can surface relevant, patient-specific data at the point of care. Addressing this gap, a new precision medicine benchmark has launched to evaluate and improve clinical LLM responses using patient-contextualized, real-world evidence.

Atropos Health (Palo Alto, CA, USA) has introduced Precision Evidence Bench, described as a first-of-its-kind precision medicine benchmark for evaluating large language models against clinical questions grounded in individual patient context and history. The benchmark measures how well models generate evidence-based answers tailored to the specific patient being assessed. Performance improved by more than 300% when models were provided Scalar Evidence Content from the company’s Alexandria Evidence Library, which contains hundreds of millions of precision Evidence-Based Findings (pEBFs), or study equivalents.

The benchmark incorporates matched patient-history context into both the clinical questions and the evaluation rubric, highlighting limitations of models that rely primarily on published literature and guidelines. Leading general large language models were tested, including GPT 5.6 Sol and Astra 6 (OpenAI), Claude Opus 5 (Anthropic), and 3.8 Flash (Google). The evaluation covered hundreds of real-world precision medicine questions spanning complex patient populations, treatments, comparators, and outcomes using the Population, Intervention, Control, Outcome (PICO) framework.

Without access to the Alexandria Evidence Library, standard models produced a complete, fully cited answer addressing all PICO criteria in only 15% of queries. Performance improved as access to precision evidence increased, with models tested again after receiving access to 100 million and then 500 million pEBFs. According to the findings, this improvement highlights how limited access to large-scale patient data can constrain commercial models when generating accurate, evidence-based recommendations for questions in which individual patient history is essential.

As part of the release, Atropos Health has made 209 benchmark questions and the accompanying scoring rubric freely available on Hugging Face, allowing researchers, healthcare organizations, and model developers to evaluate new models and track progress. The company also plans additional public updates on benchmark performance and intends to extend precision context to other public benchmarks. The Alexandria Evidence Library currently contains 500 million pEBFs and is expected to reach two billion by the end of 2026, further expanding the evidence available to support individualized clinical decision-making.

“Large language models are already very capable of interpreting and communicating medical knowledge. But many of the most important questions for clinicians and patients have never been answered by traditional research. If we want AI to support more precise healthcare decisions, we need to give them evidence to inform those decisions,” said Saurabh Gombar, MD, PhD, Chief Medical Officer of Atropos Health.

Related Links
Atropos Health


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Blood Gas Analyzer
i-Check200
Desk Aneroid Sphyg
Diagnostix 750D+
Surgical System
Stealth AXiS
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image Credit: MedUni Wien/Houdek

New Surgical Technique Enlarges Aortic Root for Larger Valve Implantation

When replacing a diseased aortic valve, a small aortic root can prevent surgeons from implanting a prosthesis large enough for the patient’s body size. This can lead to patient-prosthesis mismatch, causing... Read more

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: The tool analyzes 3D time-of-flight MR angiography to measure brain vessel length, radius, volume, branching, tortuosity, and other structural features. (Photo courtesy of University of Rochester Medical Center)

MRI Tool Analysis Identifies Vascular Differences in Cerebral Small Vessel Disease

Cerebral small vessel disease (CSVD) involves changes or damage to the brain’s small blood vessels and is associated with stroke and cognitive impairment. Magnetic resonance imaging (MRI) can show cerebral... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: The proposed acquisition would add NeoCast, an investigational next-generation liquid embolic technology for chronic subdural hematoma (cSDH), to Terumo Neuro’s neurovascular portfolio. (Photo courtesy of Arsenal Medical)

Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma

Terumo Neuro (Aliso Viejo, CA, USA) signed an agreement to acquire Arsenal Medical Inc. (Waltham, MA, USA), a privately held, clinical-stage biomaterials company. The proposed acquisition would add NeoCast,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.